|
Indian Pediatr 2010;47: 81 4 |
 |
ASV in a Neonate |
S Shanthi,
Reader in Pediatrics, Pediatric Intensive Care Unit,
Institute of Child Health, Chennai 8, India.
Email:
[email protected]
|
I would like to make a few comments regarding a recent
article(1). The current recommendation for neurotoxic envenomation
irrespective of age is to administer an initial dose of 10 vials of ASV
over one hour. A trial of neostigmine is then given and the child is
monitored. A second and final dose of 10 vials of ASV is administered 1-2
hours later if there is no improvement or worsening of symptoms(2,3).
There is no justification for using 50 vials. I would also like to
highlight the fact that the first dose of 10 vials of ASV is preferably
given over 1 hour. There is no benefit in administering each dose over a
longer period.
References
1. Jindal G, Mahajan V, Parmar VR. Antisnake venom in a
neonate with snakebite. Indian Pediatr 2010; 47; 349-350
2. Simpson ID. The pediatric management of snakebite;
the National protocol. Indian Pediatr 2007; 44: 173-176.
3. Handbook on Treatment Guidelines for Snake Bite and Scorpion Sting.
Tamil Nadu Health Systems Project,Health and Family Welfare Department,
Chennai: Government of Tamil Nadu, 2008. |
|
 |
|